secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2026-05-18T11:17:15+00:00
Accession:  0000885725-26-000042
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific enters $2B accelerated share repurchase, expects $0.02 EPS accretion in FY2026
--------------------------------------------------------------------------------

- ASR with JPMorgan for $2B; receives ~30.4M shares upfront at $52.68 (80% of repurchase price).
- Final settlement expected by June 30, 2026; total shares based on VWAP during term less discount.
- After completion, $3B remains under $5B share repurchase authorization.
- Expected net impact to adjusted EPS in FY2026 is $0.02 accretive to prior guidance (Apr 22, 2026).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572526000042/0000885725-26-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572526000042/bsx-20260518.htm
  HTML page:      https://secwatch.observer/filing/0000885725-26-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer